Surmodics to Present at 7th Annual Intellisight Investor Conference
Webcast is Live on Wednesday, August 15, at 2:30 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Aug. 7, 2018--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that it will participate in the 7th Annual
Intellisight Conference. The two-day conference, hosted by the CFA
Society of Minnesota, will take place this year on Tuesday and
Wednesday, August 14 and 15, in Minneapolis.
Tim Arens, interim vice president of finance and chief financial
officer, will present on Wednesday, August 15, at 2:30 p.m. CT
(3:30 p.m. ET). The presentation will be webcast live and can be
accessed by going to the investor relations portion of the Company’s
website at https://surmodics.gcs-web.com
and clicking on the webcast link.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests
and microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the company makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180807005131/en/
Source: Surmodics, Inc.
Tim Arens, 952-500-7000